Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation

Blood

Volumn 94, Issue 4, 1999, Pages 1465-1470

  Przepiorka, Donna ^a,b   Smith, Terry L ^a   Folloder, Jody ^a   Khouri, Issa ^a   Ueno, Naoto T ^a   Mehra, Rakesh ^a   Körbling, Martin ^a   Huh, Yang O ^a   Giralt, Sergío ^a   Gajewski, James ^a   Donato, Michele ^a   Cleary, Karen ^a   Claxton, David ^a   Braunschweig, Ira ^a   Van Besien, Koen ^a   Andersson, Borje S ^a   Anderlini, Paolo ^a   Champlin, Richard ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHOTREXATE; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033566990     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.4.1465     Document Type: Article

References (55)

1. Russell NH, Hunter A, Rogers S, Hanley J, Anderson D: Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 341:1482, 1993
2. Sasaki A, Tsukaguchi M, Hirai M, Ohira H, Nakao Y, Yamane T, Park K, Im T, Tatsumi N: Transplantation of allogeneic peripheral blood stem cells after myeloablative treatment of a patient in blastic crisis of chronic myelocytic leukemia. Am J Hematol 47:45, 1994
3. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
4. Körbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreef M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
5. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Loffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995
6. Azevedo WM, Aranha FJP, Gouvea JV, Vigorito AC, Marques Jr JFC, Eid KAB, Azevedo AM, Souza CA: Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies. Bone Marrow Transplant 16:647, 1995
7. Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb J, Storb R, Buckner CD: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation. Blood 88:2794, 1995
8. Russell JA, Brown C, Bowen T, Luider J, Ruether JD, Stewart D, Chaudhry A, Booth K, Jorgenson K, Coppes MJ, Turner AR, Larratt L, Desai S, Poon M-C, Klassen J: Allogeneic blood cell transplants for haematological malignancy: Preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 17:703, 1996
9. Przepiorka D, Ippoliti C, Khouri I, Anderlini P, Mehra R, Giralt S, Gajewski J, Fritsche H, Deisseroth AB, Cleary K, Champlin R, van Besien K, Andersson B, Körbling M: Allogeneic transplantation for advanced leukemia. Transplantation 62:1806, 1996
10. Pavletic ZS, Bishop MR, Tarantolo SR, Martin-Algarra S, Bierman PJ, Vose JM, Reed EC, Gross TG, Kollath J, Nasrati K, Jackson JD, Armitage JO, Kessinger A: Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. J Clin Oncol 15:1608, 1997
11. Serody JS, Wiley JM, Gabriel DA, Powell E, Scott C, Lawrence P, Bentley SA, Brecher ME, Folds J, Shea TC: Comparison of the use of G-CSF-stimulated peripheral blood stem cells (PBSC) or G-CSF-stimulated bone marrow (BM) in six antigen-matched sibling transplantation. Proc Am Soc Clin Oncol 17:286, 1998 (abstr)
12. Schmitz N, Bacigalupo A, Hasenclever D, Nagler A, Gluckman E, Clark P, Bourquelot P, Greinix H, Frickhofen N, Ringden O, Zander A, Apperley JF, Gorin C, Borkett K, Schwab G, Goebel M, Russell NH, Gratwohl A: Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 21:995, 1998
13. Urbano-Ispizua A, Solano C, Brunet S, Hernandez F, Sanz G, Alegre A, Petit J, Besalduch J, Vivancos P, Diaz MA, Moralda JM, Carreras E, Ojeda E, de la Rubia J, Benet I, Domingo-Albos A, Garcia-Conde J, Rozman C: Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. Bone Marrow Transplant 18:35, 1996
14. Rosenfeld C, Collins R, Pineiro L, Agura E, Nemunaitis J: Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: A Phase II study. J Clin Oncol 14:1314, 1996
15. Schmitz N, Bacigalupo A, Labopin M, Majolino I, Laporte JP, Brinch L, Cook G, Deliliers GL, Lange A, Rozman C, Garcia-Conde J, Finke J, Domingo-Albos A, Gratwohl A: Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. Br J Haematol 95: 715, 1996
16. Miflin G, Russell NH, Hutchinson RM, Morgan G, Potter M, Pagliuca A, Marsh J, Bell A, Milligan D, Lumley M, Cook G, Franklin I: Allogeneic peripheral blood stem cell transplantation for haematological malignancies - An analysis of kinetics of engraftment and GVHD risk. Bone Marrow Transplant 19:1, 1997
17. Przepiorka D, Anderlini P, Ippoliti C, Khouri I, Fietz T, Thall P, Mehra R, Giralt S, Gajewski J, Deisseroth AB, Cleary K, Champlin R, van Besien K, Andersson B, Körbling M: Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow Transplant 19:455, 1997
18. Beelen DW, Ottinger HD, Elmaagacli A, Scheulen B, Basu O, Kremens B, Havers W, Grosse-Wilde H, Schaefer UW: Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: A prospective comparison of clinical outcome, immune reconstitution, and hematopoietic chimerism. Blood 90:4725, 1997
19. Bross DS, Tutschka J, Farmer ER, Beschorner WE, Braine HG, Mellits ED, Bias WB, Santos GW: Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. Blood 63:1265, 1984
20. Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E, Good RA, Hoffmann RG, Kay H, Kersey JH, Marmont A, Masaoka T, Rimm AA, van RoodJJ, Zwaan FE: Risk factors for acute graft-versus-host disease. Br J Haematol 67:397, 1987
21. Weisdorf D, Hakke R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A: Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 51:1197, 1991
22. Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K, Martin PJ, Sullivan KM, Sanders J, Witherspoon RP: Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexale. Blood 80:1838, 1992
23. Hägglund H, Bostrom L, Remberger M, Ljungman P, Nilsson B, Ringden O: Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients. Bone Marrow Transplant 16:747, 1995
24. Gaziev D, Polchi P, Galimberti M, Angelucci E, Giardini C, Baronciani D, Erer B, Lucarelli G: Graft-versus-host disease after bone marrow transplantation for thalassemia. Transplantation 63:854, 1997
25. Khouri IF, Keating MJ, Vriesendorp HM, Reading CL, Przepiorka D, Huh YO, Andersson BS, van Besien KW, Mehra RC, Giralt S, Ippoliti C, Marshall M, Thomas MW, O'Brien S, Robertson LE, Deisseroth AB, Champlin RE: Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: Preliminary results. J Clin Oncol 12:748, 1994
26. van Besien K, Mehra R, Giralt S, Kantarjian H, Pugh W, Cabanillas F, Khouri I, Moon Y, Andersson B, Przepiorka D, McCarthy P, Gajewski J, Deisseroth A, Champlin R: Allogeneic bone marrow transplantation for poor prognosis lymphoma: Response, toxicity and survival depend on disease histology. Am J Med 100:299, 1996
27. Ueno NT, Rondon G, Mirza NQ, Geisler DK, Anderlini P, Giralt SA, Andersson BS, Claxton DF, Gajewski JL, Khouri IF, Körbling M, Mehra RC, Przepiorka D, Rahman Z, Samuels BI, van Besien K, Hortbagyi G, Champlin RE: Allogeneic peripheral blood progenitor cell transplantation for poor-risk patients with metastatic breast cancer. J Clin Oncol 16:986, 1998
28. van Besien K, Giralt S, Mehra R, Khouri I, Rodriguez A, Andersson B, Körbling M, Przepiorka D, Cabanillas F, Champlin R: High dose BEAM as conditioning for allogeneic transplantation in lymphoid malignancies. Blood 88:618a, 1996 (abstr)
29. + cells in normal donors treated with filgrastim. Transfusion 37:507, 1997
30. Snover DC: Biopsy interpretation in bone marrow transplantation, in Pathology Annual, Part 2. Rosen PP, Fechner RE (eds). Hartford, CT, Appleton & Lange, 1989, p 63
31. Przepiorka D, Weisdorf D, Martin P, Klingemann H-G, Beatty P, Hows J, Thomas ED: Consensus conference on acute GVHD grading. Bone Marrow Transplant 15:825, 1995
32. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
33. Kalbfleisch JP, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980, p 168
34. Cox DR: Regression models and life tables. J Royal Stat Soc 34:187, 1972
35. Therneau TM, Grambach PM, Fleming TR: Martingale-based residuals for survival models. Biometrika 77:147, 1990
36. Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf DJ, Fay JW, Nademanee AP, Antin JH, Christiansen NP, van der Jagt RH, Herzig RH, Litzow MR, Wolff SN, Longo WR, Petersen FB, Karanes C, Avalos BR, Storb R, Buell DN, Maher RM, Fitzsimmons WE, Wingard JR: Phase III study comparing tacrolimus with cyclosporine for graft-versus-host disease (GVHD) prophylaxis after HLA-identical sibling bone marrow transplantation (BMT). Blood 92:2303, 1998
37. Hiraoka A for the Japanese FK506 BMT Study Group: Results of a phase III study on prophylactic use of FK506 for acute GVHD compared with cyclosporin in allogeneic bone marrow transplantation. Blood 90:561a, 1997 (abstr)
38. Elmongy MB, Nevill TJ, Klingemann H-G, Shepherd JD, Reece DE, Barnett MJ, Nentel SH, Phillips GL: Cyclosporine (CSA) and methotrexate (MTX) vs CSA and methylprednisolone (MP) for graft-vs-host disease (GVHD) prophylaxis. Blood 78:233a, 1991 (abstr)
39. Sullivan KM: Graft-versus-host disease, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Cambridge, MA, Blackwell Scientific Publications, 1994, p 344
40. Sayer HG, Longton G, Bowden R, Pepe M, Storb R: Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention. Blood 84:1328, 1994
41. Bortin MM, Gale RP, Kay HEM, Rimm AA: Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. JAMA 249:1166, 1983
42. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 89:1629, 1997
43. Miller JS, Prosper F, McCullar V: Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 90:3098, 1997
44. Rutella S, Rumi C, Testa U, Sica S, Teoflli L, Martucci R, Peschle C, Leone G: Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): Possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplant 20:355, 1997
45. Tanaka J, Mielcarek M, Torok-Storb B: Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor-mobilized CD4 T cells. Blood 91:347, 1998
46. Mielcarek M, Graf L, Johnson G, Torok-Storb B: Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: A mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 92:215, 1998
47. Blazar BR, Taylot PA, Smith S, Vallera DA: Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts. Blood 85:842, 1995
48. Hempel L, Körholz D, Nuβbaum P, Bönig H, Burdach S, Zintl F: High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation. Bone Marrow Transplant 20:365, 1997
49. Kitabayashi A, Hirokawa M, Hatano Y, Lee M, Kuroki J, Niitsu H, Miura A: Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-α production. Blood 86:2220, 1995
50. Hartung T, Döcke WD, Gantner F, Krieger G, Sauer A, Stevens P, Volk HD, Wendel A: Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85:2482, 1995
51. Pollmächer T, Korth C, Mullington J, Schreiber W, Sauer J, Vedder H, Galanos C, Holsboer F: Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 87:900, 1996
52. Zeng D, Dejbakhsh-Jones S, Strober S: Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: Impact on blood progenitor cell transplantation. Blood 90:453, 1997
53. Ferrara JL, Cooke KR, Pan L, Krenger W: The immunopathophysiology of acute graft-versus-host disease. Stem Cells 14:473, 1996
54. Holler E, Kolb HJ, Hintermeier-Knabe R, Mittermüller J, Thierfelder S, Kaul M, Wilmanns W: Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. Transplant Proc 25:1234, 1993
55. Pechumer H, Leinisch E, Bender-Götze C, Ziegler-Heitbrock HWL: Recovery of monocytes after bone marrow transplantation -Rapid reappearance of tumor necrosis factor alpha and inlerleukin-6 production. Transplantation 52:698, 1991